FDA Approved: OXCARBAZEPINE — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Oxcarbazepine by Advagen Pharma Limited under ANDA 077747.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)